ClinicalTrials.gg
CompletedNCT03293212Updated Mar 29, 2019

Characteristics and Medical Resource Utilization of Postoperative Patients

An observational study in Pain, Postoperative, sponsored by Jaseng Medical Foundation. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2019-03-29.

Sponsored by Jaseng Medical Foundation · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
102
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 113 studies in Pain, Postoperative with a site in Korea, Republic of — 16 open to participants now, 19 under way, none of them phase 3. Pain, Postoperative · Korea, Republic of.

Enrollment
8th of 12
102 · median 112
Started
2017
with 5 others
Observational
12 of 113
1 open now
Registered
42nd of 113
by date

Among the 113 studies in Pain, Postoperative with a site in Korea, Republic of, this one is the 8th largest by enrollment of the 12 observational ones that give a count, is one of 6 that started in 2017, is one of 12 observational ones, and was the 42nd registered.

Pain, Postoperative

5,644 studies on the registry are indexed under Pain, Postoperative; 1,229 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

16 of the 113 studies in Pain, Postoperative with a site in Korea, Republic of are open now. Recruiting first, the newest first:

11 more — sign in →

All 16 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 241 (36%) set no upper age limit and 328 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 113 studies in Pain, Postoperative with a site in Korea, Republic of, or all of them as a file.
02

Study summary

The objective of this study is to assess and analyze the characteristics and usage of conventional and Korean medical services in postoperative patients. This study therefore investigates the proportion of patients with a history of surgery out of patients visiting a spine-specialty Korean medicine hospital, and the prognosis and preference for conventional and Korean medicine treatment by previous treatment history in postoperative patients.

Read the detailed description

A considerable number of patients suffer prolonged chronic pain that does not retract or diminish after surgery, and are thus unable to achieve the desired results in receiving surgical treatment. Postoperative pain is gradually being perceived as a social issue as opposed to a personal health condition. Meanwhile, although efforts to address chronic pain with integrative medicine are continued in answer to the lack of success of pain management through surgery, there is still a lack of supporting evidence.

The objective of this survey study is to assess the characteristics, usage of conventional and Korean medical services, and prognosis by period before and after surgery in postoperative patients visiting a Korean medicine hospital, and analyze the associations between the preference for conventional and Korean medicine treatment. This study therefore investigates the usage of conventional and Korean medical services in postoperative patients, and is expected to provide information that will potentially aid patient decision making.

03

Conditions studied

  • Pain, Postoperative

Keywords

  • Postoperative pain
  • Failed back surgery syndrome
  • Korean medicine
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients newly visiting 4 sites of Jaseng Hospital of Korean Medicine due to postoperative pain

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with chief complaint(s) of at least one or more of the following: low back pain (or radiating leg pain), neck pain (or radiating arm pain), knee pain, or shoulder pain
  • Patients with a history of musculoskeletal surgery related to the chief complaint(s)
  • Patients capable of effective communication with the researcher(s) and understanding the survey items
  • Patients who have given written

Exclusion criteria

Exclusion Criteria:

  • Patients without a history of musculoskeletal surgery associated with the low back, neck, shoulder, or knee region(s)
  • Patients whose current pain is mainly attributed to traffic accident injury
  • Patients incapable of answering the researcher interviews and surveys
  • Patients with other reasons rendering study participation inappropriate as judged by the researcher(s)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
102 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Numeric rating scale (NRS) of pain

    11-point pain scale

    Time frame: Within 7 days after 1st visit

Secondary outcomes

  1. Five level version of EuroQol-5 Dimension (EQ-5D-5L)

    Health-related quality of life questionnaire consisting of 5 descriptive items and EQ Visual Analogue Scales (EQ-VASs)

    Time frame: Within 7 days after 1st visit

  2. Functional disability questionnaire (for low back pain patients as indicated by postoperative condition)

    Oswestry Disability Index (ODI)

    Time frame: Within 7 days after 1st visit

  3. Functional disability questionnaire (for neck pain patients as indicated by postoperative condition)

    Neck Disability Index (NDI)

    Time frame: Within 7 days after 1st visit

  4. Functional disability questionnaire (for knee pain patients as indicated by postoperative condition)

    Western Ontario McMaster Universities Osteoarthritis Index (WOMAC)

    Time frame: Within 7 days after 1st visit

  5. Functional disability questionnaire (for shoulder pain patients as indicated by postoperative condition)

    Shoulder Pain and Disability Index (SPADI)

    Time frame: Within 7 days after 1st visit

  6. Work Productivity and Activity Impairment Questionnaire: General Health (WPAI-GH)

    Questionnaire assessing the effect of health problems on the ability to work and to perform regular activities

    Time frame: Within 7 days after 1st visit

  7. Beck Depression Inventory-II (BDI-II)

    The Korean version of the BDI-II has been validated and consists of 21 multiple choice items for diagnosis of depression.

    Time frame: Within 7 days after 1st visit

  8. Medical service use

    Type(s) of medical service use before and after surgery post-onset

    Time frame: Within 7 days after 1st visit

  9. Medical costs

    Medical costs from medical service use before and after surgery post-onset

    Time frame: Within 7 days after 1st visit

  10. Satisfaction with and preference for conventional and Korean medicine

    Satisfaction with and preference for conventional and Korean medicine as measured using a 9-point Likert scale

    Time frame: Within 7 days after 1st visit

07

Study locations

1 site
  • Jaseng Medical Foundation
    Seoul, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2017 to primary completion in Oct 2017, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2017
First posted
Sep 26, 2017
StartActual
Jun 29, 2017
Primary completionActual
Oct 31, 2017
CompletionActual
Oct 31, 2017
Last update
Mar 29, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 29, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03293212
Lead sponsor
Jaseng Medical Foundation
Collaborators
Korea Institute of Oriental Medicine
Responsible party
In-Hyuk Ha, KMD (Director, Jaseng Medical Foundation) — Principal investigator
First posted
Sep 26, 2017
Start date
Jun 29, 2017
Primary completion
Oct 31, 2017
Completion
Oct 31, 2017
Last update
Mar 29, 2019

Study contacts

In-Hyuk Ha, KMD, M.Sc.
principal investigator · Jaseng Medical Foundation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion